img

Global TB Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global TB Vaccines Industry Research Report, Growth Trends and Competitive Analysis 2024-2034

Tuberculosis (TB) vaccines are vaccinations intended for the prevention of tuberculosis. Immunotherapy as a defence against TB was first proposed in 1890 by Robert Koch. Today, the only effective tuberculosis vaccine in common use is bacilli Calmette-Guérin (BCG), first used in 1921.About three out of every 10,000 people who get the vaccine experience side effects, which are usually minor except in severely immuno-depressed individuals. While BCG immunization provides fairly effective protection for infants and young children, (including defence against TB meningitis and miliary TB), its efficacy in adults is variable, ranging from 0% to 80%.Several variables have been considered as responsible for the varying outcomes. Demand for TB immunotherapy advancement exists because the disease has become increasingly drug-resistant.
The global TB Vaccines market size was US$ million in 2022 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period 2024-2034.
The United States market for TB Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for TB Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for TB Vaccines is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034..
The global key manufacturers of TB Vaccines include Merck & Co.,Inc, Sanofi Pasteur, Japan BCG Laboratory, China National Biotec Group, Serum Institute, India Pvt. Ltd, InterVax Ltd, GreenSignal and Bio Pharma Limited, etc. In 2022, the global top five players hold a share approximately % in sales volume, and in term of revenue of TB Vaccines, the top five companies hold a share nearly %.
In terms of sales (consumption) side, this report focuses on the sales of TB Vaccines by regions (Countries), company, by type and by type. from 2018 to 2024 and forecast to 2034.
The global TB Vaccines market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global TB Vaccines market. These figures have been provided in terms of both revenue and sales for the period 2018-2034. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.



By Company


Merck & Co.,Inc
Sanofi Pasteur
Japan BCG Laboratory
China National Biotec Group
Serum Institute
India Pvt. Ltd
InterVax Ltd
GreenSignal
Bio Pharma Limited
Statens Serum Institut
By Type
Immunotherapeutic Vaccines
Booster Vaccines
Others
By Application
Hospitals
Private Clinics
Research Institutes
Sales by Region
North America
U.S.
Canada
China
APAC (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Sales (consumption), revenue of TB Vaccines in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3Detailed analysis of TB Vaccines manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8China by company, by type and by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, TB Vaccines sales, revenue, price, gross margin, and recent development, etc.
Chapter 12Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14The main points and conclusions of the report.

Table of Content

1 Report Overview
1.1 TB Vaccines Definition
1.2 Market by Type
1.2.1 Global TB Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Immunotherapeutic Vaccines
1.2.3 Booster Vaccines
1.2.4 Others
1.3 Market Segment by Application
1.3.1 Global TB Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Hospitals
1.3.3 Private Clinics
1.3.4 Research Institutes
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global TB Vaccines Sales
2.1 Global TB Vaccines Revenue Estimates and Forecasts 2018-2034
2.2 Global TB Vaccines Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global TB Vaccines Revenue by Region
2.3.1 Global TB Vaccines Revenue by Region (2018-2024)
2.3.2 Global TB Vaccines Revenue by Region (2024-2034)
2.4 Global TB Vaccines Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global TB Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global TB Vaccines Sales Quantity by Region
2.6.1 Global TB Vaccines Sales Quantity by Region (2018-2024)
2.6.2 Global TB Vaccines Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global TB Vaccines Sales Quantity by Manufacturers
3.1.1 Global TB Vaccines Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global TB Vaccines Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by TB Vaccines Sales in 2022
3.2 Global TB Vaccines Revenue by Manufacturers
3.2.1 Global TB Vaccines Revenue by Manufacturers (2018-2024)
3.2.2 Global TB Vaccines Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by TB Vaccines Revenue in 2022
3.3 Global TB Vaccines Sales Price by Manufacturers
3.4 Global Key Players of TB Vaccines, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of TB Vaccines, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of TB Vaccines, Product Offered and Application
3.8 Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global TB Vaccines Sales Quantity by Type
4.1.1 Global TB Vaccines Historical Sales Quantity by Type (2018-2024)
4.1.2 Global TB Vaccines Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global TB Vaccines Sales Quantity Market Share by Type (2018-2034)
4.2 Global TB Vaccines Revenue by Type
4.2.1 Global TB Vaccines Historical Revenue by Type (2018-2024)
4.2.2 Global TB Vaccines Forecasted Revenue by Type (2024-2034)
4.2.3 Global TB Vaccines Revenue Market Share by Type (2018-2034)
4.3 Global TB Vaccines Price by Type
4.3.1 Global TB Vaccines Price by Type (2018-2024)
4.3.2 Global TB Vaccines Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global TB Vaccines Sales Quantity by Application
5.1.1 Global TB Vaccines Historical Sales Quantity by Application (2018-2024)
5.1.2 Global TB Vaccines Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global TB Vaccines Sales Quantity Market Share by Application (2018-2034)
5.2 Global TB Vaccines Revenue by Application
5.2.1 Global TB Vaccines Historical Revenue by Application (2018-2024)
5.2.2 Global TB Vaccines Forecasted Revenue by Application (2024-2034)
5.2.3 Global TB Vaccines Revenue Market Share by Application (2018-2034)
5.3 Global TB Vaccines Price by Application
5.3.1 Global TB Vaccines Price by Application (2018-2024)
5.3.2 Global TB Vaccines Price Forecast by Application (2024-2034)
6 North America
6.1 North America TB Vaccines Sales by Company
6.1.1 North America TB Vaccines Revenue by Company (2018-2024)
6.1.2 North America TB Vaccines Sales Quantity by Company (2018-2024)
6.2 North America TB Vaccines Market Size by Type
6.2.1 North America TB Vaccines Sales Quantity by Type (2018-2034)
6.2.2 North America TB Vaccines Revenue by Type (2018-2034)
6.3 North America TB Vaccines Market Size by Application
6.3.1 North America TB Vaccines Sales Quantity by Application (2018-2034)
6.3.2 North America TB Vaccines Revenue by Application (2018-2034)
6.4 North America TB Vaccines Market Size by Country
6.4.1 North America TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America TB Vaccines Revenue by Country (2018-2034)
6.4.3 North America TB Vaccines Sales Quantity by Country (2018-2034)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe TB Vaccines Sales by Company
7.1.1 Europe TB Vaccines Sales Quantity by Company (2018-2024)
7.1.2 Europe TB Vaccines Revenue by Company (2018-2024)
7.2 Europe TB Vaccines Market Size by Type
7.2.1 Europe TB Vaccines Sales Quantity by Type (2018-2034)
7.2.2 Europe TB Vaccines Revenue by Type (2018-2034)
7.3 Europe TB Vaccines Market Size by Application
7.3.1 Europe TB Vaccines Sales Quantity by Application (2018-2034)
7.3.2 Europe TB Vaccines Revenue by Application (2018-2034)
7.4 Europe TB Vaccines Market Size by Country
7.4.1 Europe TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe TB Vaccines Revenue by Country (2018-2034)
7.4.3 Europe TB Vaccines Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China TB Vaccines Sales by Company
8.1.1 China TB Vaccines Sales Quantity by Company (2018-2024)
8.1.2 China TB Vaccines Revenue by Company (2018-2024)
8.2 China TB Vaccines Market Size by Type
8.2.1 China TB Vaccines Sales Quantity by Type (2018-2034)
8.2.2 China TB Vaccines Revenue by Type (2018-2034)
8.3 China TB Vaccines Market Size by Application
8.3.1 China TB Vaccines Sales Quantity by Application (2018-2034)
8.3.2 China TB Vaccines Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC TB Vaccines Sales by Company
9.1.1 APAC TB Vaccines Sales Quantity by Company (2018-2024)
9.1.2 APAC TB Vaccines Revenue by Company (2018-2024)
9.2 APAC TB Vaccines Market Size by Type
9.2.1 APAC TB Vaccines Sales Quantity by Type (2018-2034)
9.2.2 APAC TB Vaccines Revenue by Type (2018-2034)
9.3 APAC TB Vaccines Market Size by Application
9.3.1 APAC TB Vaccines Sales Quantity by Application (2018-2034)
9.3.2 APAC TB Vaccines Revenue by Application (2018-2034)
9.4 APAC TB Vaccines Market Size by Region
9.4.1 APAC TB Vaccines Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC TB Vaccines Revenue by Region (2018-2034)
9.4.3 APAC TB Vaccines Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America TB Vaccines Sales by Company
10.1.1 Middle East, Africa and Latin America TB Vaccines Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America TB Vaccines Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America TB Vaccines Market Size by Type
10.2.1 Middle East, Africa and Latin America TB Vaccines Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America TB Vaccines Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America TB Vaccines Market Size by Application
10.3.1 Middle East, Africa and Latin America TB Vaccines Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America TB Vaccines Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America TB Vaccines Market Size by Country
10.4.1 Middle East, Africa and Latin America TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America TB Vaccines Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America TB Vaccines Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck & Co.,Inc
11.1.1 Merck & Co.,Inc Company Information
11.1.2 Merck & Co.,Inc Overview
11.1.3 Merck & Co.,Inc TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck & Co.,Inc TB Vaccines Products and Services
11.1.5 Merck & Co.,Inc TB Vaccines SWOT Analysis
11.1.6 Merck & Co.,Inc Recent Developments
11.2 Sanofi Pasteur
11.2.1 Sanofi Pasteur Company Information
11.2.2 Sanofi Pasteur Overview
11.2.3 Sanofi Pasteur TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Sanofi Pasteur TB Vaccines Products and Services
11.2.5 Sanofi Pasteur TB Vaccines SWOT Analysis
11.2.6 Sanofi Pasteur Recent Developments
11.3 Japan BCG Laboratory
11.3.1 Japan BCG Laboratory Company Information
11.3.2 Japan BCG Laboratory Overview
11.3.3 Japan BCG Laboratory TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Japan BCG Laboratory TB Vaccines Products and Services
11.3.5 Japan BCG Laboratory TB Vaccines SWOT Analysis
11.3.6 Japan BCG Laboratory Recent Developments
11.4 China National Biotec Group
11.4.1 China National Biotec Group Company Information
11.4.2 China National Biotec Group Overview
11.4.3 China National Biotec Group TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 China National Biotec Group TB Vaccines Products and Services
11.4.5 China National Biotec Group TB Vaccines SWOT Analysis
11.4.6 China National Biotec Group Recent Developments
11.5 Serum Institute
11.5.1 Serum Institute Company Information
11.5.2 Serum Institute Overview
11.5.3 Serum Institute TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 Serum Institute TB Vaccines Products and Services
11.5.5 Serum Institute TB Vaccines SWOT Analysis
11.5.6 Serum Institute Recent Developments
11.6 India Pvt. Ltd
11.6.1 India Pvt. Ltd Company Information
11.6.2 India Pvt. Ltd Overview
11.6.3 India Pvt. Ltd TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 India Pvt. Ltd TB Vaccines Products and Services
11.6.5 India Pvt. Ltd TB Vaccines SWOT Analysis
11.6.6 India Pvt. Ltd Recent Developments
11.7 InterVax Ltd
11.7.1 InterVax Ltd Company Information
11.7.2 InterVax Ltd Overview
11.7.3 InterVax Ltd TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 InterVax Ltd TB Vaccines Products and Services
11.7.5 InterVax Ltd TB Vaccines SWOT Analysis
11.7.6 InterVax Ltd Recent Developments
11.8 GreenSignal
11.8.1 GreenSignal Company Information
11.8.2 GreenSignal Overview
11.8.3 GreenSignal TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 GreenSignal TB Vaccines Products and Services
11.8.5 GreenSignal TB Vaccines SWOT Analysis
11.8.6 GreenSignal Recent Developments
11.9 Bio Pharma Limited
11.9.1 Bio Pharma Limited Company Information
11.9.2 Bio Pharma Limited Overview
11.9.3 Bio Pharma Limited TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 Bio Pharma Limited TB Vaccines Products and Services
11.9.5 Bio Pharma Limited TB Vaccines SWOT Analysis
11.9.6 Bio Pharma Limited Recent Developments
11.10 Statens Serum Institut
11.10.1 Statens Serum Institut Company Information
11.10.2 Statens Serum Institut Overview
11.10.3 Statens Serum Institut TB Vaccines Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 Statens Serum Institut TB Vaccines Products and Services
11.10.5 Statens Serum Institut TB Vaccines SWOT Analysis
11.10.6 Statens Serum Institut Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 TB Vaccines Value Chain Analysis
12.2 TB Vaccines Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 TB Vaccines Production Mode & Process
12.4 TB Vaccines Sales and Marketing
12.4.1 TB Vaccines Sales Channels
12.4.2 TB Vaccines Distributors
12.5 TB Vaccines Customers
13 Market Dynamics
13.1 TB Vaccines Industry Trends
13.2 TB Vaccines Market Drivers
13.3 TB Vaccines Market Challenges
13.4 TB Vaccines Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global TB Vaccines Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Immunotherapeutic Vaccines
Table 3. Major Manufacturers of Booster Vaccines
Table 4. Major Manufacturers of Others
Table 5. Global TB Vaccines Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global TB Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global TB Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 8. Global TB Vaccines Revenue Market Share by Region (2018-2024)
Table 9. Global TB Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 10. Global TB Vaccines Revenue Market Share by Region (2024-2034)
Table 11. Global TB Vaccines Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 12. Global TB Vaccines Sales by Region (2018-2024) & (K Units)
Table 13. Global TB Vaccines Sales Market Share by Region (2018-2024)
Table 14. Global TB Vaccines Sales by Region (2024-2034) & (K Units)
Table 15. Global TB Vaccines Sales Market Share by Region (2024-2034)
Table 16. Global TB Vaccines Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 17. Global TB Vaccines Sales Quantity Share by Manufacturers (2018-2024)
Table 18. Global TB Vaccines Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 19. Global TB Vaccines Revenue Share by Manufacturers (2018-2024)
Table 20. Global TB Vaccines Price by Manufacturers 2018-2024 (USD/Unit)
Table 21. Global Key Players of TB Vaccines, Industry Ranking, 2021 VS 2022
Table 22. Global TB Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global TB Vaccines by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in TB Vaccines as of 2022)
Table 24. Global Key Manufacturers of TB Vaccines, Manufacturing Base Distribution and Headquarters
Table 25. Global Key Manufacturers of TB Vaccines, Product Offered and Application
Table 26. Global Key Manufacturers of TB Vaccines, Date of Enter into This Industry
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 29. Global TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 30. Global TB Vaccines Sales Quantity Share by Type (2018-2024)
Table 31. Global TB Vaccines Sales Quantity Share by Type (2024-2034)
Table 32. Global TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 33. Global TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 34. Global TB Vaccines Revenue Share by Type (2018-2024)
Table 35. Global TB Vaccines Revenue Share by Type (2024-2034)
Table 36. TB Vaccines Price by Type (2018-2024) & (USD/Unit)
Table 37. Global TB Vaccines Price Forecast by Type (2024-2034) & (USD/Unit)
Table 38. Global TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 39. Global TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 40. Global TB Vaccines Sales Quantity Share by Application (2018-2024)
Table 41. Global TB Vaccines Sales Quantity Share by Application (2024-2034)
Table 42. Global TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 43. Global TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 44. Global TB Vaccines Revenue Share by Application (2018-2024)
Table 45. Global TB Vaccines Revenue Share by Application (2024-2034)
Table 46. TB Vaccines Price by Application (2018-2024) & (USD/Unit)
Table 47. Global TB Vaccines Price Forecast by Application (2024-2034) & (USD/Unit)
Table 48. North America TB Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 49. North America TB Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 50. North America TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 51. North America TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 52. North America TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 53. North America TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 54. North America TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 55. North America TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 56. North America TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 57. North America TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 58. North America TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 59. North America TB Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 60. North America TB Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 61. North America TB Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 62. North America TB Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 63. Europe TB Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 64. Europe TB Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 65. Europe TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 66. Europe TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 67. Europe TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 68. Europe TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 69. Europe TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 70. Europe TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 71. Europe TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 72. Europe TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 73. Europe TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 74. Europe TB Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 75. Europe TB Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 76. Europe TB Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 77. Europe TB Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 78. China TB Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 79. China TB Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 80. China TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 81. China TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 82. China TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 83. China TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 84. China TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 85. China TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 86. China TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 87. China TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 88. APAC TB Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 89. APAC TB Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 90. APAC TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 91. APAC TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 92. APAC TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 93. APAC TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 94. APAC TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 95. APAC TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 96. APAC TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 97. APAC TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 98. APAC TB Vaccines Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 99. APAC TB Vaccines Revenue by Region (2018-2024) & (US$ Million)
Table 100. APAC TB Vaccines Revenue by Region (2024-2034) & (US$ Million)
Table 101. APAC TB Vaccines Sales Quantity by Region (2018-2024) & (K Units)
Table 102. APAC TB Vaccines Sales Quantity by Region (2024-2034) & (K Units)
Table 103. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Company (2018-2024) & (K Units)
Table 104. Middle East, Africa and Latin America TB Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 105. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Type (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Type (2024-2034) & (K Units)
Table 107. Middle East, Africa and Latin America TB Vaccines Revenue by Type (2018-2024) & (US$ Million)
Table 108. Middle East, Africa and Latin America TB Vaccines Revenue by Type (2024-2034) & (US$ Million)
Table 109. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Application (2018-2024) & (K Units)
Table 110. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Application (2024-2034) & (K Units)
Table 111. Middle East, Africa and Latin America TB Vaccines Revenue by Application (2018-2024) & (US$ Million)
Table 112. Middle East, Africa and Latin America TB Vaccines Revenue by Application (2024-2034) & (US$ Million)
Table 113. Middle East, Africa and Latin America TB Vaccines Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 114. Middle East, Africa and Latin America TB Vaccines Revenue by Country (2018-2024) & (US$ Million)
Table 115. Middle East, Africa and Latin America TB Vaccines Revenue by Country (2024-2034) & (US$ Million)
Table 116. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Country (2018-2024) & (K Units)
Table 117. Middle East, Africa and Latin America TB Vaccines Sales Quantity by Country (2024-2034) & (K Units)
Table 118. Merck & Co.,Inc Company Information
Table 119. Merck & Co.,Inc Description and Overview
Table 120. Merck & Co.,Inc TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 121. Merck & Co.,Inc TB Vaccines Product and Services
Table 122. Merck & Co.,Inc TB Vaccines SWOT Analysis
Table 123. Merck & Co.,Inc Recent Developments
Table 124. Sanofi Pasteur Company Information
Table 125. Sanofi Pasteur Description and Overview
Table 126. Sanofi Pasteur TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 127. Sanofi Pasteur TB Vaccines Product and Services
Table 128. Sanofi Pasteur TB Vaccines SWOT Analysis
Table 129. Sanofi Pasteur Recent Developments
Table 130. Japan BCG Laboratory Company Information
Table 131. Japan BCG Laboratory Description and Overview
Table 132. Japan BCG Laboratory TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 133. Japan BCG Laboratory TB Vaccines Product and Services
Table 134. Japan BCG Laboratory TB Vaccines SWOT Analysis
Table 135. Japan BCG Laboratory Recent Developments
Table 136. China National Biotec Group Company Information
Table 137. China National Biotec Group Description and Overview
Table 138. China National Biotec Group TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 139. China National Biotec Group TB Vaccines Product and Services
Table 140. China National Biotec Group TB Vaccines SWOT Analysis
Table 141. China National Biotec Group Recent Developments
Table 142. Serum Institute Company Information
Table 143. Serum Institute Description and Overview
Table 144. Serum Institute TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 145. Serum Institute TB Vaccines Product and Services
Table 146. Serum Institute TB Vaccines SWOT Analysis
Table 147. Serum Institute Recent Developments
Table 148. India Pvt. Ltd Company Information
Table 149. India Pvt. Ltd Description and Overview
Table 150. India Pvt. Ltd TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 151. India Pvt. Ltd TB Vaccines Product and Services
Table 152. India Pvt. Ltd TB Vaccines SWOT Analysis
Table 153. India Pvt. Ltd Recent Developments
Table 154. InterVax Ltd Company Information
Table 155. InterVax Ltd Description and Overview
Table 156. InterVax Ltd TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 157. InterVax Ltd TB Vaccines Product and Services
Table 158. InterVax Ltd TB Vaccines SWOT Analysis
Table 159. InterVax Ltd Recent Developments
Table 160. GreenSignal Company Information
Table 161. GreenSignal Description and Overview
Table 162. GreenSignal TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 163. GreenSignal TB Vaccines Product and Services
Table 164. GreenSignal TB Vaccines SWOT Analysis
Table 165. GreenSignal Recent Developments
Table 166. Bio Pharma Limited Company Information
Table 167. Bio Pharma Limited Description and Overview
Table 168. Bio Pharma Limited TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 169. Bio Pharma Limited TB Vaccines Product and Services
Table 170. Bio Pharma Limited TB Vaccines SWOT Analysis
Table 171. Bio Pharma Limited Recent Developments
Table 172. Statens Serum Institut Company Information
Table 173. Statens Serum Institut Description and Overview
Table 174. Statens Serum Institut TB Vaccines Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (USD/Unit) and Gross Margin (2018-2024)
Table 175. Statens Serum Institut TB Vaccines Product and Services
Table 176. Statens Serum Institut TB Vaccines SWOT Analysis
Table 177. Statens Serum Institut Recent Developments
Table 178. Key Raw Materials Lists
Table 179. Raw Materials Key Suppliers Lists
Table 180. TB Vaccines Distributors List
Table 181. TB Vaccines Customers List
Table 182. TB Vaccines Market Trends
Table 183. TB Vaccines Market Drivers
Table 184. TB Vaccines Market Challenges
Table 185. TB Vaccines Market Restraints
Table 186. Research Programs/Design for This Report
Table 187. Key Data Information from Secondary Sources
Table 188. Key Data Information from Primary Sources
List of Figures
Figure 1. TB Vaccines Product Picture
Figure 2. Global TB Vaccines Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global TB Vaccines Market Share by Type in 2022 & 2034
Figure 4. Immunotherapeutic Vaccines Product Picture
Figure 5. Booster Vaccines Product Picture
Figure 6. Others Product Picture
Figure 7. Global TB Vaccines Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global TB Vaccines Market Share by Application in 2022 & 2034
Figure 9. Hospitals
Figure 10. Private Clinics
Figure 11. Research Institutes
Figure 12. TB Vaccines Report Years Considered
Figure 13. Global TB Vaccines Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global TB Vaccines Revenue 2018-2034 (US$ Million)
Figure 15. Global TB Vaccines Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 16. Global TB Vaccines Sales Quantity 2018-2034 (K Units)
Figure 17. Global TB Vaccines Sales Quantity Market Share by Region (2018-2024)
Figure 18. Global TB Vaccines Sales Quantity Market Share by Region (2024-2034)
Figure 19. North America TB Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 20. North America TB Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 21. Europe TB Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 22. Europe TB Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 23. China TB Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 24. China TB Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 25. APAC TB Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 26. APAC TB Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 27. Middle East, Africa and Latin America TB Vaccines Sales Quantity YoY (2018-2034) & (K Units)
Figure 28. Middle East, Africa and Latin America TB Vaccines Revenue YoY (2018-2034) & (US$ Million)
Figure 29. The Top 10 and Top 5 Players Market Share by TB Vaccines Sales Quantity in 2022
Figure 30. The Top 10 and Top 5 Players Market Share by TB Vaccines Revenue in 2022
Figure 31. TB Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 32. Global TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 33. Global TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 34. Global TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 35. Global TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 36. North America TB Vaccines Revenue Market Share by Company in 2022
Figure 37. North America TB Vaccines Sales Quantity Market Share by Company in 2022
Figure 38. North America TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 39. North America TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 40. North America TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 41. North America TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 42. North America TB Vaccines Revenue Share by Country (2018-2034)
Figure 43. North America TB Vaccines Sales Quantity Share by Country (2018-2034)
Figure 44. U.S. TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 45. Canada TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 46. Europe TB Vaccines Sales Quantity Market Share by Company in 2022
Figure 47. Europe TB Vaccines Revenue Market Share by Company in 2022
Figure 48. Europe TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 49. Europe TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 50. Europe TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 51. Europe TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 52. Europe TB Vaccines Revenue Share by Country (2018-2034)
Figure 53. Europe TB Vaccines Sales Quantity Share by Country (2018-2034)
Figure 54. Germany TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 55. France TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 56. U.K. TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 57. Italy TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 58. Russia TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 59. China TB Vaccines Sales Quantity Market Share by Company in 2022
Figure 60. China TB Vaccines Revenue Market Share by Company in 2022
Figure 61. China TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 62. China TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 63. China TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 64. China TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 65. APAC TB Vaccines Sales Quantity Market Share by Company in 2022
Figure 66. APAC TB Vaccines Revenue Market Share by Company in 2022
Figure 67. APAC TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 68. APAC TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 69. APAC TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 70. APAC TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 71. APAC TB Vaccines Revenue Share by Region (2018-2034)
Figure 72. APAC TB Vaccines Sales Quantity Share by Region (2018-2034)
Figure 73. Japan TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 74. South Korea TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 75. China Taiwan TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 76. Southeast Asia TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 77. India TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 78. Middle East, Africa and Latin America TB Vaccines Sales Quantity Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America TB Vaccines Revenue Market Share by Company in 2022
Figure 80. Middle East, Africa and Latin America TB Vaccines Sales Quantity Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America TB Vaccines Revenue Market Share by Type (2018-2034)
Figure 82. Middle East, Africa and Latin America TB Vaccines Sales Quantity Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America TB Vaccines Revenue Market Share by Application (2018-2034)
Figure 84. Middle East, Africa and Latin America TB Vaccines Sales Quantity Share by Country (2018-2034)
Figure 85. Middle East, Africa and Latin America TB Vaccines Revenue Share by Country (2018-2034)
Figure 86. Brazil TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 87. Mexico TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 88. Turkey TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 89. Israel TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 90. GCC Countries TB Vaccines Revenue (2018-2034) & (US$ Million)
Figure 91. TB Vaccines Value Chain
Figure 92. TB Vaccines Production Process
Figure 93. Channels of Distribution (Direct Vs Distribution)
Figure 94. Distributors Profiles
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed